Workflow
MASH cirrhosis with portal hypertension
icon
Search documents
Galectin Therapeutics Inc. (GALT) Discusses Updated Results for Belapectin in Treatment of MASH Cirrhosis and Portal Hypertension Transcript
Seeking Alpha· 2026-03-10 18:30
PresentationI'd now like to turn the call over to your moderator, Michael Cozart of LifeSci Consulting. Please go ahead, Michael.Good afternoon, and welcome to the Galectin Therapeutics Virtual KOL event. [Operator Instructions] As a reminder, this call is being recorded, and a replay will be made available on the Galectin website following the conclusion of the event.Michael Cozart Thanks, Tara, and good afternoon, everyone, and thank you for joining today's KOL webinar. My name is Michael Cozart, and I'm ...
Galectin Therapeutics (NasdaqCM:GALT) Update / briefing Transcript
2026-03-10 17:02
Galectin Therapeutics (NasdaqCM:GALT) Update / briefing March 10, 2026 12:00 PM ET Company ParticipantsKhurram Jamil - CMOMichael Cozart - Managing PartnerNaga P. Chalasani - David W. Crabb Professor of Gastroenterology and HepatologyNaim Alkhouri - Chief Academic OfficerOperatorGood afternoon, and welcome to the Galectin Therapeutics Virtual KOL event. At this time, all attendees are in a listen-only mode. A question and answer session will follow formal presentations. If you'd like to submit a question, y ...